In one paragraphArticle in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors at 1 institution in 1 country.
Ana Rita MiraH&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal.
Ana Sofia ZeferinoEscola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal.
Raquel InácioCIMOSM-Centro de Investigação em Modelação e Otimização de Sistemas Multifuncionais, ISEL-Instituto Superior de Engenharia de Lisboa, Instituto, Politécnico de Lisboa, R. Conselheiro Emidio Navarro 1, 1959-007 Lisboa, Portugal.
Mariana DelgadinhoH&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal.ORCID 0000-0003-0586-9154 Miguel BritoH&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal.ORCID 0000-0001-6394-658X Cecília R C CaladoCIMOSM-Centro de Investigação em Modelação e Otimização de Sistemas Multifuncionais, ISEL-Instituto Superior de Engenharia de Lisboa, Instituto, Politécnico de Lisboa, R. Conselheiro Emidio Navarro 1, 1959-007 Lisboa, Portugal.ORCID 0000-0002-5264-9755 Edna RibeiroH&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal.ORCID 0000-0003-1316-7750 Instituto Politécnico de Lisboa · PT
Funding
Instituto Politécnico de Lisboa IPL/2020/ EpiResistanceSA _ESTeSL
6 · The paper itselfAbstract
Healthcare-associated methicillin-resistant
Indexed as
drug resistance modulatorsdrug resistance phenotypesepigallocatechin-3-gallate (EGCG)epigenetic modulatorhealthcare-associated S. aureus infectionssynergistic effects
Identifiers
PMID36978386
PMCPMC10044528
OpenAlexW4323318895
What OpenQuestion holds
Textfull text, public
LicenceCC BY
measurements read46
Read underepoch 390